Table 2.
Index | Placebo | Infliximab 3 mg kg−1/4 weeks | (P values vs placebo) 3 mg kg−1/8 weeks | 10 mg kg−1/4 weeks | 10 mg kg−1/8 weeks |
---|---|---|---|---|---|
ACR20 | 20% | 53% | 50% | 58% | 52% |
(P < 0.001) | (P < 0.001) | (P < 0.001) | (P < 0.001) | ||
ACR50 | 5% | 29% | 27% | 26% | 31% |
(P < 0.001) | (P < 0.001) | (P < 0.001) | (P < 0.001) | ||
ACR70 | 0% | 11% | 8% | 11% | 18% |
(P < 0.001) | (P = 0.002) | (P = 0.007) | (P = 0.002) |